ClinicalTrials.Veeva

Menu

Effects of Intermittent Fasting and Exercise on Inflammation, Metabolism, and the Microbiome in Metabolic Syndrome (FIT)

U

University of Erlangen-Nürnberg Medical School

Status

Enrolling

Conditions

Obesity and Obesity-related Medical Conditions
Metabolic Syndrome

Treatments

Other: Time restricted eating
Other: Alternate day fasting
Other: High-intensity interval training

Study type

Interventional

Funder types

Other

Identifiers

NCT06885255
22-60_2-B

Details and patient eligibility

About

The goal of this intervention trial is to assess the effects of intermittent fasting, both alone and in combination with high-intensity interval training, on patients with obesity and metabolic syndrome. The main question it aims to answer is:

Does intermittent fasting, with or without high-intensity interval training, reduce chronic inflammation in patients with obesity and metabolic syndrome?

Participants will follow an intermittent fasting regime for 3 months, with one intervention group additionally participating in high-intensity interval training twice a week. In addition, there are two control groups: one consisting of participants with metabolic syndrome and one consisting of generally healthy individuals. The study includes a 3-month intervention phase followed by a 3-month follow-up phase. During the 6-month study period, all participants will attend 6 in-house study visits and 2 phone visits, during which they will undergo assessments and receive nutritional counseling.

Enrollment

250 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Written consent to participate in the study.
  • Persons aged 18 years and older.
  • Diagnosis of Metabolic Syndrome (MetS) with elevated hsCRP.

Exclusion criteria

  • Pregnant or nursing individuals.
  • Cardiovascular diseases or orthopedic restrictions that prevent exercise.
  • Use of medication or supplements that significantly affect study outcomes (e.g., anti-inflammatory medications, antibiotics within the last 6 weeks).
  • Body weight greater than 200 kg (maximum capacity of training equipment).
  • Individuals with mental illnesses that may impair their ability to understand or participate in the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

250 participants in 5 patient groups

Metabolic syndrome - alternate day fasting
Experimental group
Description:
Patients with metabolic syndrome who undergo alternate-day fasting in addition to regular advice on the mediterranean diet
Treatment:
Other: Alternate day fasting
Metabolic syndrome - time restricted eating
Experimental group
Description:
Patients with metabolic syndrome who undergo time restricted eating in addition to regular advice on the mediterranean diet
Treatment:
Other: Time restricted eating
Metabolic syndrome - time restricted eating plus high-intensity interval training
Experimental group
Description:
Patients with metabolic syndrome who undergo time restricted eating plus high-intensity interval training in addition to regular advice on the mediterranean diet
Treatment:
Other: High-intensity interval training
Other: Time restricted eating
Metabolic syndrome - controls
No Intervention group
Description:
Patients with metabolic syndrome exclusively receiving regular advice on the mediterranean diet
Healthy - controls
No Intervention group
Description:
Healthy controls exclusively receiving regular advice on the mediterranean diet

Trial contacts and locations

1

Loading...

Central trial contact

Prof. Dr. med. Yurdagül Zopf

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems